Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
Fierce Pharma
Wed, 03/5/25 - 11:59 am
Novo Nordisk
DTC
Wegovy
Eli Lilly
weight loss
drug compounding
New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach
Pharma Voice
Tue, 03/4/25 - 09:51 am
Voyager Therapeutics
RNA
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Where Will Eli Lilly Be in 5 Years?
Motley Fool
Sun, 03/2/25 - 09:41 pm
Eli Lilly
diabetes
obesity
cancer
ulcerative colitis
Lilly hops on hot molecular glue train with $1.6B+ Magnet deal
BioSpace
Fri, 02/28/25 - 11:24 am
Eli Lilly
Magnet Biomedicine
molecular glue
Eli Lilly unveils plan for four U.S. "mega-sites"
Axios
Wed, 02/26/25 - 11:02 am
Eli Lilly
drug manufacturing
reshoring
Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company
Yahoo Finance
Tue, 02/25/25 - 10:38 pm
Organovo
Eli Lilly
FXR agonists
IBD
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
CNBC
Tue, 02/25/25 - 11:14 am
Eli Lilly
Zepbound
weight loss
LillyDirect
Trump administration, pharma clash: 4 notes
Beckers Hospital Review
Mon, 02/24/25 - 04:54 pm
Donald Trump
tariffs
Eli Lilly
Merck
Pfizer
PhRMA
Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4
Fierce Pharma
Mon, 02/24/25 - 11:09 am
earnings
Big Pharma
Eli Lilly
Novo Nordisk
Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile
US News and World Report
Thu, 02/20/25 - 06:07 pm
Eli Lilly
weight loss
obesity
clinical trials
orforglipron
Insurers push back on Medicare and Medicaid coverage for GLP-1s
Axios
Thu, 02/20/25 - 11:37 am
insurers
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Mounjaro
Wegovy
Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO
Pharma Voice
Thu, 02/20/25 - 11:35 am
Immunocore
Travis Coy
Eli Lilly
M&A
Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production
Pharma Voice
Wed, 02/19/25 - 09:44 am
Merck
Eli Lilly
R&D
drug manufacturing
Young Institute Pharmaceutical Manufacturing Consortium
AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment
Pharmaceutical Business Review
Tue, 02/11/25 - 11:27 am
radiopharmaceuticals
Eli Lilly
AdvanCell
cancer
alpha radiation
Wegovy and Ozempic stars dim amid overuse concerns
Axios
Tue, 02/11/25 - 11:17 am
Wegovy
Ozempic
Zepbound
Mounjaro
Novo Nordisk
Eli Lilly
GLP-1 agonists
obesity
patients
physicians
side effects
South Korean Biotech Firm Olix Exports MASH Treatment to Eli Lilly for 910 Billion Won
Business Korea
Mon, 02/10/25 - 10:24 pm
Eli Lilly
MASH
South Korea
Olix Pharmaceuticals
Eli Lilly reports positive data from trial of Omvoh for Crohn’s disease
Clinical Trials Arena
Mon, 02/10/25 - 10:17 am
Eli Lilly
Crohn's Disease
clinical trials
Omvoh
Eli Lilly’s earnings, shares lifted by obesity drug sales
BioPharma Dive
Thu, 02/6/25 - 10:40 pm
Eli Lilly
earnings
Lilly’s investigational Alzheimer’s to be investigated in prevention trial
Clinical Trials Arena
Wed, 02/5/25 - 11:14 am
clinical trials
Eli Lilly
remternetug
Alzheimer's disease
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Forbes
Fri, 01/31/25 - 10:59 am
surgery
GLP-1 agonists
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »